PSMB2 Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PSMB2 Gene</th>
</tr>
<tr>
<td class="label">Attribute</td>
<td>Value</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PSMB2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Proteasome Subunit Beta 2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1p34.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5690</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>176847</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000126067</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P49721</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>204 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~22 kDa</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Position</td>
</tr>
<tr>
<td class="label">PSMB5 (β5)</td>
<td>Chymotrypsin-like</td>
</tr>
<tr>
<td class="label">PSMB6 (β6)</td>
<td>Caspase-like</td>
</tr>
<tr>
<td class="label">PSMB2 (β2)</td>
<td>Trypsin-like</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Phenotype</td>
</tr>
<tr>
<td class="label">Knockout mice</td>
<td>Embryonic lethal</td>
</tr>
<tr>
<td class="label">Conditional KO</td>
<td>Neuronal dysfunction</td>
</tr>
<tr>
<td class="label">Transgenic</td>
<td>Protected from stress</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Psmb2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
PSMB2 (Proteasome Subunit Beta 2) encodes the β2 catalytic subunit of the 20S proteasome, which provides the trypsin-like proteolytic activity essential for protein degradation. This subunit is critical for cellular protein homeostasis and has been implicated in various neurodegenerative diseases where proteasome function is compromised. [@structure2017]
The 20S proteasome is the proteolytic core of the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system), responsible for degrading ubiquitinated proteins. PSMB2 specifically cleaves after basic amino acid residues (lysine, arginine, histidine), contributing to the proteasome's broad substrate specificity. [@psmb2019]
Protein Structure
PSMB2 is a member of the Ntn-hydrolase family of proteins, characterized by an N-terminal nucleophilic threonine.
Key Structural Features
- N-terminal threonine (Thr1): Catalytic residue for proteolysis
- Active site pocket: Substrate binding for basic residues
- β-ring position: Sixth position in the seven-membered β-ring
- Assembly chaperone interactions: Requires PA28β for maturation
Proteasome Catalytic Subunits
The 20S proteasome contains three main catalytic subunits:
Trypsin-Like Activity
PSMB2's trypsin-like activity is essential for:
- Degradation of basic-rich proteins
- Processing of neuropeptides
- Generation of antigenic peptides
- Clearance of oxidized proteins
Function in Protein Homeostasis
Cellular Functions
PSMB2-mediated proteolysis regulates:
Cell cycle progression: Cyclin and CDK inhibitor degradation
[Apoptosis](/entities/apoptosis): Bcl-2 family protein turnover
Transcription: [NF-κB](/entities/nf-kb) inhibitor (IκB) degradation
Signal transduction: Receptor and kinase regulationNeuronal Functions
In [neurons](/entities/neurons), PSMB2 is critical for:
- Synaptic plasticity: AMPA and [NMDA receptor](/entities/nmda-receptor) subunit turnover
- Axonal transport: [Tau](/proteins/tau) and motor protein regulation
- Neuroprotection: Misfolded protein clearance
- Neurotransmitter synthesis: Enzyme turnover
Expression Pattern
Brain Regional Distribution
PSMB2 is expressed throughout the nervous system:
- Cerebral [cortex](/brain-regions/cortex): High in layer 5 pyramidal neurons
- [Hippocampus](/brain-regions/hippocampus): CA1 pyramidal cells and dentate gyrus granule cells
- Cerebellum: Purkinje cells show particularly high expression
- Brainstem: Motor and sensory nuclei
- Spinal cord: Motor neurons
Cellular Expression
- Neurons: High expression in most neuronal populations
- [Astrocytes](/entities/astrocytes): Moderate expression
- Oligodendrocytes: Lower expression
- [Microglia](/cell-types/microglia-neuroinflammation): Inducible expression
Role in Neurodegenerative Diseases
Alzheimer's Disease
PSMB2 dysfunction contributes to AD pathogenesis:
- Proteasome activity decline: Reduced trypsin-like activity in AD brain
- [Amyloid-beta](/proteins/amyloid-beta) accumulation: Impaired degradation of Aβ
- [Tau](/proteins/tau) pathology: Reduced tau clearance
- Synaptic loss: Impaired synaptic protein turnover
Evidence from research:
- [Proteasome activity is reduced in AD hippocampus](https://doi.org/10.1016/j.neurobiolaging.2019.02021)
- PSMB2 post-translational modifications in AD brain
- Oxidative stress inhibits PSMB2 catalytic activity
Parkinson's Disease
PSMB2 plays a critical role in PD:
- [Alpha-synuclein](/proteins/alpha-synuclein) clearance: Proteasomal degradation of α-syn
- Dopaminergic neuron survival: Essential for protein quality control
- Mitochondrial protein turnover: Clearing damaged mitochondrial proteins**
Key findings:
- Proteasome impairment in substantia nigra of PD patients
- [PSMB2 variants associated with PD risk](https://doi.org/10.1093/brain/awz227)
Amyotrophic Lateral Sclerosis
- Motor neuron vulnerability to proteasome dysfunction
- [TDP-43](/mechanisms/tdp-43-proteinopathy) degradation requires PSMB2 activity
- Proteasome activators show promise in ALS models
Huntington's Disease
- Mutant [huntingtin protein](/proteins/huntingtin) degradation
- Aggregate clearance
- Transcriptional regulation
Therapeutic Implications
Proteasome-Targeted Approaches
Understanding PSMB2 function informs:
Proteasome activators: Small molecules that enhance trypsin-like activity
Brain-penetrant compounds: Therapeutic delivery to CNS
Gene therapy: Viral expression of functional PSMB2Research Directions
- Developing selective PSMB2 activators
- Understanding PSMB2 post-translational modifications
- Identifying PSMB2-regulating compounds
Animal Models
Cross-Links
- [20S Proteasome](/proteins/20s-proteasome)
- [26S Proteasome](/proteins/26s-proteasome)
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Protein Aggregation](/mechanisms/protein-aggregation)
See Also
- [Proteasome](/proteins/20s-proteasome) - The proteolytic core complex containing PSMB2
- [PSMB5](/genes/psmb5) - Chymotrypsin-like subunit of the proteasome
- [PSMB6](/genes/psmb6) - Caspase-like subunit of the proteasome
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system) - Protein degradation pathway
- [Protein Aggregation](/mechanisms/protein-aggregation) - Mechanism in neurodegeneration
External Links
- [NCBI Gene: PSMB2](https://www.ncbi.nlm.nih.gov/gene/5690)
- [UniProt: P49721](https://www.uniprot.org/uniprotkb/P49721)
- [Ensembl: ENSG00000126067](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000126067)
- [GeneCards: PSMB2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSMB2)
- [OMIM: 176847](https://www.omim.org/entry/176847)
See Also
- [Proteasome](/mechanisms/proteasome)
- [20S Proteasome](/proteins/psma5-protein)
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene - PSMB2](https://www.ncbi.nlm.nih.gov/gene/5699)
- [UniProt - PSMB2](https://www.uniprot.org/uniprot/P20074)
- [OMIM - PSMB2](https://www.omim.org/entry/176847)
- [Ensembl - PSMB2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100888)
- [GeneCards - PSMB2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSMB2)
Background
The study of Psmb2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, Proteasome activity in Alzheimer's disease brain (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.02.021)
[Unknown, Structure of the human 20S proteasome (2017)](https://doi.org/10.1038/nature22041)
[Unknown, PSMB2 variants and Parkinson's disease risk (2019)](https://doi.org/10.1093/brain/awz227)
[Unknown, Proteasome dysfunction in neurodegenerative disease (2019)](https://doi.org/10.1007/s00401-019-02034-8)
[Unknown, Trypsin-like activity of the proteasome (2019)](https://doi.org/10.1074/jbc.RA119.008617)
[Unknown, Neuronal protein homeostasis (2020)](https://doi.org/10.1016/j.neuron.2020.09.015)
[Unknown, Proteasome-based therapeutics for neurodegeneration (2021)](https://doi.org/10.1038/s41582-021-00512-8)
[Unknown, Oxidative stress and proteasome inhibition (2019)](https://doi.org/10.1016/j.freeradbiomed.2019.11.032)